Axon Enterprise, Inc $AXON Shares Sold by Oppenheimer & Co. Inc.

Oppenheimer & Co. Inc. cut its stake in Axon Enterprise, Inc (NASDAQ:AXON) by 24.3% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 6,944 shares of the biotechnology company’s stock after selling 2,231 shares during the period. Oppenheimer & Co. Inc.’s holdings in Axon Enterprise were worth $4,983,000 at the end of the most recent reporting period.

Other institutional investors have also modified their holdings of the company. Brighton Jones LLC purchased a new position in Axon Enterprise in the 4th quarter valued at approximately $480,000. NewEdge Advisors LLC boosted its position in Axon Enterprise by 41.1% during the first quarter. NewEdge Advisors LLC now owns 2,294 shares of the biotechnology company’s stock worth $1,207,000 after purchasing an additional 668 shares in the last quarter. Empowered Funds LLC grew its holdings in Axon Enterprise by 8.4% in the first quarter. Empowered Funds LLC now owns 2,028 shares of the biotechnology company’s stock valued at $1,067,000 after purchasing an additional 157 shares during the last quarter. Woodline Partners LP increased its position in shares of Axon Enterprise by 40.6% in the first quarter. Woodline Partners LP now owns 6,932 shares of the biotechnology company’s stock valued at $3,646,000 after buying an additional 2,003 shares in the last quarter. Finally, Sivia Capital Partners LLC purchased a new position in shares of Axon Enterprise in the second quarter valued at $284,000. Hedge funds and other institutional investors own 79.08% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities research analysts recently commented on the stock. The Goldman Sachs Group decreased their price objective on shares of Axon Enterprise from $940.00 to $800.00 and set a “buy” rating on the stock in a research report on Wednesday, November 5th. Piper Sandler cut their target price on shares of Axon Enterprise from $893.00 to $753.00 and set an “overweight” rating for the company in a research report on Wednesday, November 5th. Northcoast Research raised shares of Axon Enterprise from a “neutral” rating to a “buy” rating and set a $742.00 price target on the stock in a report on Tuesday, January 6th. Barclays dropped their price objective on shares of Axon Enterprise from $861.00 to $702.00 and set an “overweight” rating for the company in a research note on Thursday, November 6th. Finally, Wall Street Zen downgraded Axon Enterprise from a “hold” rating to a “sell” rating in a research report on Saturday, November 8th. Fifteen analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $805.71.

Insider Buying and Selling

In other Axon Enterprise news, CFO Brittany Bagley sold 2,000 shares of the stock in a transaction on Thursday, December 11th. The stock was sold at an average price of $580.00, for a total transaction of $1,160,000.00. Following the transaction, the chief financial officer owned 103,501 shares of the company’s stock, valued at $60,030,580. This represents a 1.90% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this link. Also, CEO Patrick W. Smith sold 10,000 shares of the firm’s stock in a transaction on Monday, December 8th. The stock was sold at an average price of $551.92, for a total value of $5,519,200.00. Following the sale, the chief executive officer owned 3,110,997 shares in the company, valued at $1,717,021,464.24. This trade represents a 0.32% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 48,040 shares of company stock worth $27,249,338 in the last three months. 4.40% of the stock is currently owned by insiders.

Axon Enterprise Stock Performance

NASDAQ:AXON opened at $434.45 on Thursday. The company has a debt-to-equity ratio of 0.57, a current ratio of 3.12 and a quick ratio of 2.89. The firm has a market cap of $34.28 billion, a PE ratio of 137.48, a P/E/G ratio of 13.46 and a beta of 1.48. The firm has a 50 day simple moving average of $562.29 and a 200-day simple moving average of $652.35. Axon Enterprise, Inc has a 1-year low of $396.41 and a 1-year high of $885.91.

Key Stories Impacting Axon Enterprise

Here are the key news stories impacting Axon Enterprise this week:

• Positive Sentiment: RBC Capital reaffirmed its Buy rating on Axon, providing analyst support that can underpin the stock into the earnings release. RBC Capital Sticks to Their Buy Rating for Axon Enterprise (AXON)
• Positive Sentiment: Syracuse Common Council voted to install Axon license-plate readers despite pushback — a local deployment that supports recurring hardware/software revenues, though the vote drew protests. Syracuse Common Council votes to install Axon readers despite pushback
• Neutral Sentiment: Axon announced its Q4 2025 earnings date for Feb 24 after the close — a clear near-term catalyst that could swing the stock. Axon to Release Fourth Quarter 2025 Earnings on February 24, 2026
• Neutral Sentiment: Public filings show Advisors Asset Management trimmed a small position (2,132 shares) in Axon — a minor institutional sell that is unlikely to be a major directional force by itself. Advisors Asset Management Inc. Sells 2,132 Shares of Axon Enterprise, Inc $AXON
• Neutral Sentiment: Reported short-interest data in the feeds is effectively zero/uncertain (shows 0 shares and NaN changes) — not a reliable signal for current crowd positioning. Axon Enterprise (AXON) Sees a More Significant Dip Than Broader Market: Some Facts to Know
• Negative Sentiment: Broader negative sentiment in software stocks and commentary that Axon has fallen sharply in the sector sell-off are press headwinds; analysts note earnings-estimate revision trends may limit upside. Software Bear Market: 1 SaaS Stock To Buy Now, 1 To Avoid
• Negative Sentiment: Local protests and controversy around license-plate readers (coverage of meetings where protesters were removed) add political and reputational risk that could complicate municipal rollouts in some jurisdictions. Protesters removed from Syracuse Common Council meeting during vote on license plate readers

Axon Enterprise Company Profile

Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company’s hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.

Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.